Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank Drug (Description in trials) KEGG GENES KEGG PATHWAY Disease ID
1 Daunorubicin 💬[1] Dextromethorphan (Dextromethorphan hydrobromide monohydrate)[2] Dextromethorphan; Dextromethorphan hydrobromide--[9] 6, 8, 13, 21, 46, 85, 96, 97, 156 💬
2 Dextromethorphan 💬
(Dextromethorphan (USP))		[1] Dextromethorphan (Dextromethorphan hydrobromide monohydrate)[2] Dextromethorphan; Dextromethorphan hydrobromide[6] GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬 		[21] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬[9] 6, 8, 13, 21, 46, 85, 96, 97, 156 💬
3 Dextromethorphan hydrobromide 💬
(Dextromethorphan hydrobromide (USP), Dextromethorphan hydrobromide hydrate (JP18))		[1] Dextromethorphan (Dextromethorphan hydrobromide monohydrate)[2] Dextromethorphan; Dextromethorphan hydrobromide[6] GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬 		[21] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬[9] 6, 8, 13, 21, 46, 85, 96, 97, 156 💬